chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after 1 day I had the vaccine I start to feel tired and my joints became swollen and I had aches in all the joints of my upper body.
TDAP vaccination was administered to this patient on 10/19/2023. The patient?s mom brought in a vaccine record that did not reflect that TDAP was given in Aug 2023, prior to her bringing  in the vaccination record when she initially scheduled the visit, I had initially searched the system and could not find the patient?s record. Then I requested that the mom bring in vaccination records she has for him. I relied on the record she brought, I should have gone back to check again, to avoid giving the TDAP too close to the previous dose. It is obvious now that the patient's info was incorrectly  entered in system that was why his record couldn't be found initially.
Dizziness, mostly all at night when I lay down to go to sleep; Weakness; I am always tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 19Feb2021 (Lot number: EN6201) as dose 2,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1,SINGLE LOT#EL9265), administration date: 29Jan2021, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset 2021, outcome "unknown", described as "Dizziness, mostly all at night when I lay down to go to sleep"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "Weakness"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "I am always tired".  Additional information : When probed for the concern, consumer stated, "I am not sure, if I am to the right place. I got the second shot on 19Feb2021, Now it was "32" (not clarified) days after my first shot which was 19Feb my first shot. I have been having a problem with some dizziness, mostly all at night when I lay down to go to sleep and after the fact I get the second shot that whatever they are could cause dizziness and weakness, I am always tired, so I don't know what is the weakness would be and I would be concerned about was this dizziness was caused by the shot because it appeared after "32" (not clarified) days of the shot."     No follow-up attempts are possible. No further information is expected.
103.7 F FEVER; A spontaneous report has been received from a consumer concerning a female patient (age 5 years).    No medical history was reported. Concomitant medication included influenza vaccine live reassort 3v.     On an unknown date, the patient received Flumist Quadrivalent (influenza vaccine live reassort 4v) (batch number Unknown) unknown, via nasal route.     A Unknown administered FLUMIST QUADRIVALENT. No malfunction has been reported for this combination product.    On 02-Nov-2023, the patient experienced 103.7 f fever (preferred term: Pyrexia).     Action taken with suspect Flumist Quadrivalent was Not Applicable.    On 03-Nov-2023, the patient recovered from the event 103.7 f fever.     The event of 103.7 f fever was upgraded by the company physician from non-serious to serious due to seriousness criteria of important medical event.    Laboratory values are available.    Device Information:     Combination Product Report: Yes    Product As Reported: FLUMIST QUADRIVALENT  Common Device Name: Nasal Spray  Procode: CCQ  Product Role: Suspect; Sender's Comments: Pyrexia is not listed in the company core data sheet of Q/LAIV. Due to limited information on indication, action taken, start date, circumstances leading to the event, concurrent conditions, concomitant medications, relevant medical history, risk factors leading to the event (infectious diseases), detailed etiological and diagnostic workup (complete blood analysis including infectious disease profile, relevant imaging studies), the evaluation did not find evidence to suggest a reasonable possibility of a causal relationship between the event and Q/LAIV.
incorrect route of product administration; shaky; lightheaded; fever; sore arm; cold sweats; no strength,very weak; slept all day; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweats), ASTHENIA (no strength,very weak), SOMNOLENCE (slept all day), TREMOR (shaky), DIZZINESS (lightheaded) and PYREXIA (fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060A21A  or 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Confined in the hospital for 3 weeks) on 23-Oct-2020.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced COLD SWEAT (cold sweats) (seriousness criterion medically significant), ASTHENIA (no strength,very weak) (seriousness criterion medically significant), SOMNOLENCE (slept all day) (seriousness criterion medically significant), PYREXIA (fever) (seriousness criterion medically significant) and PAIN IN EXTREMITY (sore arm). On 24-May-2021, the patient experienced TREMOR (shaky) (seriousness criterion medically significant) and DIZZINESS (lightheaded) (seriousness criterion medically significant). On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (incorrect route of product administration). On 21-May-2021, PAIN IN EXTREMITY (sore arm) had resolved. On 24-May-2021, COLD SWEAT (cold sweats), ASTHENIA (no strength,very weak), SOMNOLENCE (slept all day) and PYREXIA (fever) had resolved. On 27-May-2021, TREMOR (shaky) and DIZZINESS (lightheaded) had resolved. At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (incorrect route of product administration) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-May-2021, Oxygen saturation: 82% percent (Low) decreased 82%.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided Treatment included oxygen inhalation to 8l pm Patient stated that she discharged on NOV 2020 with oxygen inhalation of 5lpm during night time and 2.5-3 lpm as needed during day time.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Patient received a shingles and influenza vaccines, one in each arm on 11/15/18. Developed a rash on his left torso with a half-dollar size, red, irritated and grouped together. Pt. denied any pain, chills, fever. Pt. was prescribed acyclovir 400 mg TID x 5 days. Rx was mailed out.
Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Death occurred out of state and no details were provided. Patient was 86 with CHF and requiring a pacemaker. Call to nurse on 2/17/21 showed complaints of SOB with sats in the 80s but declined suggestions to go to ER
Patient left the vaccine area and about 5 min later fainted at the store entrance area. No signs before shots were given. Patient mentioned after fainting she had no food in her today and only 2 cups of coffee.
Could barely breathe for 35-45 minutes; Inability to speak; Chills, violent shaking; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Could barely breathe for 35-45 minutes), APHASIA (Inability to speak) and CHILLS (Chills, violent shaking) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced DYSPNOEA (Could barely breathe for 35-45 minutes), APHASIA (Inability to speak) and CHILLS (Chills, violent shaking). In January 2021, DYSPNOEA (Could barely breathe for 35-45 minutes), APHASIA (Inability to speak) and CHILLS (Chills, violent shaking) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  Treatment details were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 30-MAY-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot# R021077, expiration date: 11-JUN-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674:
Short of breath; I am having difficulty is shortness of breath; It's nauseating pain that I am having in my stomach; It's nauseating pain that I am having in my stomach; Very strong stomach discomfort; This is a spontaneous report from a contactable consumer reporting for himself. A 79-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 27Jan2021 (Batch/Lot Number: EL9261) as dose 1, single (age at vaccination: 79-year-old) for covid-19 immunization. Medical history included Blood pressure high from an unknown, knee surgery from 25Jan2021. Concomitant medication included clonidine 0.1 mg, taken for hypertension, start and stop date were not reported. On unknown date in 2021 (reported as couple days after I got my shot), the patient experienced "short of breath; I am having difficulty is shortness of breath, it's nauseating pain that I am having in my stomach, very strong stomach discomfort, And I can't shake it". Consumer stated, he had his COVID 19 Shot, first one and he think it was done last month on the 28th he believes (clarified as 27Jan2021). Because his next follow-up shot was going to on the 19th of this month that will be on 19Feb2021. And his symptoms were that he was short of breath and he was also having very strong stomach discomfort. And its nauseating pain that he was having in his stomach. And he could not shake it. And he doesn't know if there was something to do with the vaccine or something completely different. So, he was just wondering. He had gone through some lab test in last 2 weeks because he just had knee surgery, he had a knee surgery. And he that, his knee surgery was on the 25th of last month, it was 25Jan2021 when his knee surgery done. Lab test were apparently well, they were good, there was no reason for him not to have his knee surgery. He did pass COVID 19 nasal test for negativity, before the operation. And so, he had his blood work done and everything else was done before the surgery. Patient told the events were started couple days after he got his shot and was still experiencing. Patient did not take any medication for treatment because he doesn't know what it was. The only thing that was recommended to him was to eat some yogurt. The only other thing that he was having difficulty in shortness of breath, also that he noticed after getting the shot. The patient underwent lab tests and procedures which included blood test: unknown result, Lab test: they were good, sars-cov-2 test: negativity on an unknown date in 2021. The outcome for all events was not resolved.  Follow-up attempts completed. No further information expected.
Pfizer booster was ordered for patient by provider. Primary series vaccine was administered instead of booster series.
Moderate flue-like symptoms (malaise, anergia, headaches, myalgia, chills, skin hypersensitivity) throughout the day following the second dose of the Moderna vaccine.
No adverse effects were reported; The physician reports that on 5/31/2019, one dose of improperly stored PROQUAD) was administered to P.V; This spontaneous report was received from a physician concerning unspecified patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug allergies or reactions, historical and concomitant drugs were not reported.  On 31-MAY-2019, the patient was vaccinated with one dose of improperly stored dose of varicella virus vaccine live (Oka/Merck)(VARIVAX) for prophylaxis (lot number R021098 with expiration date on 23-JUL-2020, route of administration, strength and frequency were not reported). Other suspect therapy included sterile diluent for prophylaxis (lot number N032755 with expiration date on 04-AUG-2020, route of administration, strength and frequency were not reported).  Administered doses of vaccine experienced temperature excursion between 15 degrees Fahrenheit up to 46 degrees Fahrenheit (36 Fahrenheit) for 8 hours and temperature excursion between 6 degrees Fahrenheit up to 14 degrees Fahrenheit (14 Fahrenheit) for 15 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA000968: US-009507513-1906USA001161:
leukemia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), in 2017 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LEUKAEMIA (medically significant), outcome "unknown", described as "leukemia". Additional information: patient had the Prevnar 13 5 years ago (2017) and mentioned that he has a form of leukemia. He wanted to know if he could get Prevnar 20. Patient had a leukemia after getting prevnar13.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Special Population : younger than 18 years old; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Special Population : younger than 18 years old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse event reported).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Special Population : younger than 18 years old). On 12-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Special Population : younger than 18 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number unknown) with no associated AEs reported
large red blemishes on my legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (large red blemishes on my legs) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) unknown. On an unknown date, the patient experienced RASH MACULAR (large red blemishes on my legs). At the time of the report, RASH MACULAR (large red blemishes on my legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
1st vaccine  dec 18th : arm pain for 3 days  ,    felt sick within 2 hours with headache and  fever and chills  temp at that time 100 degrees , :  fever 100 to 101  degrees on day 1 , 2 , 3 , 100  degrees  on  day 4 , day 5 ,  myalgia , body aches   and headaches  daily  week 1 and     fatigue  week 2   was bed bound for 2 days  and then could not  work  for 3 days after that  2nd vaccine om 1/8/21 : left arm pain within 5 to 10 mins of  injection  with burning , pain and tingling ,  headache  and feverish  feeling and chills started within 2 hours , severe myalgia  and  body ache and  headache   day 1 and day 2 ,    on round the clock tyelenol every 6 hours ,  temp max recorded 100.6
pt recv vax 12MAY95 & 20MAY97 pt devel 15 chickenpox;26MAY97 pt recovered;
soreness of upper arm; Looks like phlebitis; upper arm Warm to touch; redness of upper arm; itching of upper arm; hardness of upper arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of upper arm), PHLEBITIS (Looks like phlebitis), INJECTION SITE WARMTH (upper arm Warm to touch), ERYTHEMA (redness of upper arm) and PRURITUS (itching of upper arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DEXLANSOPRAZOLE (DEXILANT), AMLODIPINE, EZETIMIBE, LEVOTHYROXINE, BACLOFEN, DULOXETINE, BISOPROLOL, PANTOPRAZOLE and LISINOPRIL for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness of upper arm), PHLEBITIS (Looks like phlebitis), INJECTION SITE WARMTH (upper arm Warm to touch), ERYTHEMA (redness of upper arm), PRURITUS (itching of upper arm) and INJECTION SITE INDURATION (hardness of upper arm). At the time of the report, PAIN IN EXTREMITY (soreness of upper arm), PHLEBITIS (Looks like phlebitis), INJECTION SITE WARMTH (upper arm Warm to touch), ERYTHEMA (redness of upper arm), PRURITUS (itching of upper arm) and INJECTION SITE INDURATION (hardness of upper arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
1st Vaccine shot-FRI APR 23, 0900 9hrs later, shot area sore, next morning SAT approx 330am woke up to migraine that lasted till noon SAT. Afternoon fatigue /tired / dizzy; *started weezing , nose felt stuffy-took 1 puff inhaler. Sun 25- breathing normal, no inhaler, but by mid day both hands-ALL fingers tight / stiff/ bones sore - pain lasted approx 1 day, stiffness in joints lingering. Mon 26- bone joint / stiffness somewhat subsides, constant Left hip bone pain, intermittent heat sensation / like hot flashes- ongoing until current. May 2-3-weezing is back, stuffy nose - 1 puff inhaler per day. May 3- approx. 0500am bright red blood found in stool. Stool normal size / color, blood in feces, no blood when I wipe. No odd smell, no difficulty in moving bowls, no stomach pain.  Appetite & sleep pattern is normal, no fever.
Rt arm started swelling about the size of a nickle.   Site warm and painful.  No signs of infection.
Narrative:  Patient reported dizziness, and joint stiffness following administration of second dose of Pfizer covid vaccine. Patient required no intervention and was able to depart on their own.
Day after second dose decedent had fever and tremors, subsided on day three (less than 72 hours) after dose with exterem wekness followed by death less than 72 hours after second dose
patient reports that 5 min after vaccine, felt hot, heart racing, she reports HR went to 150 and she felt like she was going to pass out. Since then patient has felt chest pain, numbness toe to head on the left side, right elbow numbness, warmth abdomen and chest seen in the ER 12/30/2021 01/01/22 01/04/2022 and 01/08/22
Initial report received from a consumer on 08 August 2008. A 63-year-old female patient received a left deltoid intramuscular injection of DECAVAC (lot number not reported) and a right deltoid intramuscular injection of PNEUMOVAX (manufacturer Merck, lot number not reported) on 20 March 2008. Three to four days after vaccinations, the patient experienced generalized illness and began sleeping a lot. Within 12 days after vaccinations, the patient experienced digestive distress, including abdominal pain that caused her to double over. The pain came in waves and lasted several hours. The patient also experienced abdominal swelling and diarrhea, which lasted for two months, then mostly resolved. On an unspecified date, the patient experienced swelling and pain in the left deltoid which lasted one month. After the swelling decreased, tenderness continued. Tenderness, noticed upon touching the area, lasted for one month. Three weeks after the vaccinations, the patient broke out in a raised, itchy rash. Some bumps were red, varied slightly in size and were very small. The rash appeared on her face, arms and back and lasted approximately two months. Three to four weeks after the vaccinations, the patient began experiencing memory problems. She also began to slow down physically, became sluggish, felt groggy and was not as alert as usual. Her hands had swollen to the point where she had gone up one ring size. At this same time, the patient also began having a tingling feeling in her arms and hands, which was felt more in the right hand than the left. In April 2008, the patient began having headaches nearly every day. The headache pain woke her from her sleep. Once she got up out of bed and began moving about, the headaches would subside. Headaches are still occurring, but have tapered off; they were more frequent over a two month period, and have began to occur less frequently over months three and four. Six to eight weeks after the vaccinations, the patient experienced dry, red eyes. The patient also developed swelling in the neck and it was painful to move her head. In addition, the patient had upper back pain in the shoulder area. At the time of the report, the patient reported feeling much better, but was still not her usual self. Some symptoms persisted. The patient added that, at one point during this time (onset date not reported), she also had aching in the elbows of both arms. She experienced what she believed was a "circulatory problem", which included leg pain in addition to numbness in the legs when sitting for an extended period of time. Outcome was reported as 'not recovered'. Follow-up information was received 14 October 2008 from a physician. The physician confirmed the lot number for ADACEL had been U2287CA and the lot number for PNEUMOVAX had been 1035F. Per the physician, the patient refused to be seen for follow-up. The physician reviewed the case information and had no additional information to provide at this time.